Change location:

Healthcare Professionals

Proveca medicines for children

This section is intended for Healthcare Professionals only and contains promotional content.

Sialanar® (320mcg/ml glycopyrronium equivalent to 400mcg/ml glycopyrronium bromide)

Sialanar® is indicated for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

Sialanar® UK Prescribing Information

If you would like to find out further information on Sialanar® (including various educational and supporting resources) please visit the Sialanar® website.

Please click here to visit the Sialanar® website

Aqumeldi® (enalapril maleate) 0.25mg orodispersible tablets

Aqumeldi® is indicated for the treatment of heart failure in children from birth to less than 18 years.

Aqumeldi® UK Prescribing Information

If you would like to find out further information on Aqumeldi® please visit the Aqumeldi® page.

Please click here to visit the Aqumeldi® page

Please see information below to report adverse events in the UK

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Proveca Limited.
Phone: 0333 200 1866 E-mail: medinfo@proveca.com

This is our UK website, intended for UK Healthcare Professionals (HCPs). Our global and country sites can be reached by the selection bar in the top right hand corner.